XTNT Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of --. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Picard Medical's return on equity of --.

Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 150.92%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Xtant Medical Holdings, Inc. has higher upside potential than Picard Medical, analysts believe Xtant Medical Holdings, Inc. is more attractive than Picard Medical.

Xtant Medical Holdings, Inc. has a beta of -0.052, which suggesting that the stock is 105.153% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Picard Medical quarterly revenues of --. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Picard Medical's net income of --. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 58.61x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.65x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

Sensus Healthcare, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -13.7%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Sensus Healthcare, Inc.'s return on equity of -5.65%.

Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 150.92%. On the other hand Sensus Healthcare, Inc. has an analysts' consensus of $7.33 which suggests that it could grow by 82.88%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Sensus Healthcare, Inc..

Xtant Medical Holdings, Inc. has a beta of -0.052, which suggesting that the stock is 105.153% less volatile than S&P 500. In comparison Sensus Healthcare, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.559%.

Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sensus Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Sensus Healthcare, Inc. pays out -- of its earnings as a dividend.

Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Sensus Healthcare, Inc. quarterly revenues of $6.9M. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Sensus Healthcare, Inc.'s net income of -$943K. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 58.61x while Sensus Healthcare, Inc.'s PE ratio is 34.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.65x versus 1.84x for Sensus Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -862.39%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat VolitionRX Ltd.'s return on equity of --.

Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 150.92%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that VolitionRX Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe VolitionRX Ltd. is more attractive than Xtant Medical Holdings, Inc..

Xtant Medical Holdings, Inc. has a beta of -0.052, which suggesting that the stock is 105.153% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 58.61x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.65x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -1037.17%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Catheter Precision, Inc.'s return on equity of -192.05%.

Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 150.92%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1496.69%. Given that Catheter Precision, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Catheter Precision, Inc. is more attractive than Xtant Medical Holdings, Inc..

Xtant Medical Holdings, Inc. has a beta of -0.052, which suggesting that the stock is 105.153% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 58.61x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.65x versus 11.19x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.